XML 43 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
The components of stock-based compensation expense for all of the Company’s stock-based plans
The table below summarizes the components of stock-based compensation expense for all of the Company’s stock-based plans by award type for the indicated periods:
 
 
Year ended December 31,
 
 
2013
 
2012
 
2011
 
 
 
 
 
 
 
Time-vested deferred stock
 
$
1,829

 
$
1,920

 
$
1,625

Stock appreciation rights
 
618

 
647

 
850

Performance-based share awards
 
48

 
631

 
721

Stock purchase plan
 
68

 
126

 
162

Stock options
 
264

 
90

 
—

Total stock-based compensation
 
$
2,827

 
$
3,414

 
$
3,358
Summary of the Company's equity activity
The following table summarizes the Company’s TVDS activity and related information for the indicated periods:
 
 
Time Vested Deferred Stock
 
Weighted-Average
Grant Date
Fair Value
 
Weighted-Average Remaining Contractual Life (In Years)
 
 
 
 
 
 
 
Outstanding non-vested as of December 31, 2010
 
218

 
$
16.57

 
 
Granted
 
305

 
14.74

 
 
Vested
 
(70
)
 
20.59

 
 
Canceled
 
(37
)
 
15.16

 
 
Outstanding non-vested as of December 31, 2011
 
416

 
14.68

 
 
Granted
 
104

 
17.14

 
 
Vested
 
(95
)
 
12.89

 
 
Canceled
 
(25
)
 
13.43

 
 
Outstanding non-vested as of December 31, 2012
 
400

 
15.82

 
 
Granted
 
104

 
15.21

 
 
Vested
 
(92
)
 
14.98

 
 
Canceled
 
(33
)
 
15.17

 
 
Outstanding non-vested as of December 31, 2013
 
379

 
14.69

 
2.5
Schedule of share equivalents
 
 
December 31,
 
 
2013
 
2012
 
2011
 
 
 
 
 
 
 
Dividend participation
 
$
332

 
$
370

 
$
241

Closing market price per share
 
$
18.53

 
$
17.13

 
$
13.81

Equivalent shares at closing market price
 
18

 
22

 
17
Summary of the range of assumptions used to estimate the fair values of SARs granted
The following table summarizes the range of assumptions used to estimate the fair values of SARs granted for the indicated periods:
 
 
Year ended December 31,
 
 
2012
 
2011
 
 
 
 
 
Risk-free interest rate
 
0.72%
 
0.87-2.37%
Expected life
 
4.3 years
 
4.5 years
Expected stock price volatility
 
56%
 
54-60%
Expected dividend yield
 
3.47%
 
2.71-4.97%
Summary of the Company’s SARs activity and related information
The following table summarizes the Company’s SARs activity and related information for the indicated periods:
 
 
SARs
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Life (in Years)
 
Aggregate Intrinsic Value
 
 
 
 
 
 
 
 
 
Outstanding as of December 31, 2010
 
695

 
$
19.47

 
 
 
 
Granted
 
429

 
13.15

 
 
 
 
Exercised
 
(22
)
 
10.06

 
 
 
 
Canceled
 
(136
)
 
15.70

 
 
 
 
Expired
 
(109
)
 
24.49

 
 
 
 
Outstanding as of December 31, 2011
 
857

 
16.51

 
 
 
 
Granted
 
18

 
14.99

 
 
 
 
Exercised
 
(79
)
 
10.88

 
 
 
 
Canceled
 
(69
)
 
13.38

 
 
 
 
Expired
 
(99
)
 
22.99

 
 
 
 
Outstanding as of December 31, 2012
 
628

 
16.53

 
 
 
 
Exercised
 
(53
)
 
11.54

 
 
 
 
Canceled
 
(16
)
 
12.10

 
 
 
 
Expired
 
(66
)
 
25.65

 
 
 
 
Outstanding as of December 31, 2013
 
493

 
15.98

 
3.0
 
$
1,999

Exercisable as of December 31, 2013
 
287

 
18.02

 
2.3
 
863

Exercisable and expected to vest as of December 31, 2013
 
434

 
16.52

 
2.9
 
1,613
Company’s PCDS activity and related information
The following table summarizes the Company’s performance-based share awards activity and related information for the indicated periods:
 
 
Performance-based Share Awards
 
Weighted-Average
Grant Date
Fair Value
 
Weighted-Average Remaining Contractual Life (in Years)
 
 
 
 
 
 
 
Outstanding as of December 31, 2010
 
—

 
$
—

 
 
Granted
 
133

 
13.67

 
 
Canceled
 
(26
)
 
13.64

 
 
Outstanding as of December 31, 2011
 
107

 
13.67

 
 
Granted
 
82

 
17.36

 
 
Vested
 
(50
)
 
13.67

 
 
Canceled
 
(32
)
 
16.02

 
 
Outstanding as of December 31, 2012
 
107

 
15.78

 
 
Vested
 
(46
)
 
14.00

 
 
Canceled
 
(19
)
 
17.36

 
 
Outstanding as of December 31, 2013
 
42

 
17.36

 
3.2
Summary of the Company’s stock option activity and related information
The following table summarizes the Company’s stock option activity and related information for the indicated periods:
 
 
Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Life (in Years)
 
Aggregate Intrinsic Value
 
 
 
 
 
 
 
 
 
Outstanding as of December 31, 2010
 
155

 
$
23.57

 
 
 
 
Canceled
 
(50
)
 
16.05

 
 
 
 
Expired
 
(105
)
 
27.15

 
 
 
 
Outstanding as of December 31, 2011
 
—

 
—

 
 
 
 
Granted
 
154

 
17.36

 
 
 
 
Canceled
 
(10
)
 
17.36

 
 
 
 
Outstanding as of December 31, 2012
 
144

 
17.36

 
 
 
 
Granted
 
127

 
16.80

 
 
 
 
Canceled
 
(11
)
 
17.36

 
 
 
 
Outstanding as of December 31, 2013
 
260

 
17.09

 
6.4
 
$
375